This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

What are Clinical Trials?

Clinical trials play an important role in the development of new treatment opportunities. Patients can decide voluntarily to take part in them. The studies are subject to a strict quality control plan in order to guarantee the safety of the participants. 

To obtain an approval for a clinical trial of the European Medicines Agency (EMA) or the Food and Drug Administration (FDA), the results from the preclinical phase have to be known. Therefore, the scrutinizing substance is tested for possible dangerous effects in labs. After the drug is considered to be safe, it gets the permission for clinical trials. These are divided in three phases, where efficacy and safety of the investigating substance is evaluated in a large number of patients (more than 100 or 1000). 

Clinical trials involving new drugs are commonly classified into several phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will normally proceed through four phases over many years. If the drug successfully passes through the phases 1, 2 and 3 it will usually be approved by the national regulatory authority for use in the general population.

Adapted from: Wikipedia. Phases of clinical research: Summary. 2017. Retrieved from https://en.wikipedia.org/wiki/Phases_of_clinical_research. Accessed on 07.25.2017.